CGT Catapult leads industry consortium developing universal test to increase the safety and efficiency of stem cell therapies
Press Release December 10th, 2025
Rinri Therapeutics awarded $1m Grand Prize at Life Sciences Innovation Summit in Riyadh, Saudi Arabia
Press Release October 2nd, 2025
Mytos Announces Strategic Partnerships with StemSight, Rinri Therapeutics, and Novadip to Power Next-Generation Cell Therapy Trials
Press Release September 3rd, 2025
UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss
Press Release July 1st, 2025
Rinri Therapeutics starts transformational year at JP Morgan conference, discussing upcoming first-in-human trial in neural hearing loss
Press Release January 14th, 2025
Novel procedure for cell delivery in Rinri Therapeutics’ first clinical trial described in peer-reviewed publication
Press Release November 11th, 2024
Rinri Therapeutics latest article has been published by Otology and Neurotology.
Press Release July 2nd, 2024
Rinri Therapeutics Announces New Chair as It Approaches First Clinical Trial
Press Release April 29th, 2024
World’s first self-monitored cochlear implant trial opens the door to future hearing loss therapies
Press Release December 13th, 2022
International research coalition verifies safe surgical access to the central core of the human cochlea for the very first time
Press Release November 9th, 2022